|
|
|
|
|||||
|
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost  |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| CRMD | Pfaffle Antony | Chief Scientific Officer | Feb 07 '17 | Option Exercise | 0.68 | 10,000 | 6,800 | 10,000 | Feb 08 04:01 PM |
| CRMD | Pfaffle Antony | Chief Scientific Officer | Feb 07 '17 | Sale | 2.00 | 10,000 | 20,000 | 0 | Feb 08 04:01 PM |
| CRMD | Pfaffle Antony | Chief Scientific Officer | Oct 21 '16 | Option Exercise | 0.68 | 20,000 | 13,600 | 20,000 | Oct 25 04:32 PM |
| CRMD | Pfaffle Antony | Chief Scientific Officer | Oct 21 '16 | Sale | 2.23 | 20,000 | 44,600 | 0 | Oct 25 04:32 PM |
| CRMD | Pfaffle Antony | Interim Chief Medical Officer | Jun 20 '16 | Option Exercise | 0.68 | 10,000 | 6,800 | 10,000 | Jun 22 04:30 PM |
| CRMD | Pfaffle Antony | Interim Chief Medical Officer | Jun 21 '16 | Option Exercise | 0.68 | 19,657 | 13,367 | 19,657 | Jun 22 04:30 PM |
| CRMD | Pfaffle Antony | Interim Chief Medical Officer | Jun 21 '16 | Sale | 2.13 | 19,657 | 41,772 | 0 | Jun 22 04:30 PM |
| CRMD | Pfaffle Antony | Interim Chief Medical Officer | Jun 20 '16 | Sale | 2.16 | 10,000 | 21,568 | 0 | Jun 22 04:30 PM |
| CRMD | Pfaffle Antony | Interim Chief Medical Officer | Jun 15 '16 | Option Exercise | 0.68 | 4,900 | 3,332 | 4,900 | Jun 16 05:03 PM |
| CRMD | Pfaffle Antony | Interim Chief Medical Officer | Jun 15 '16 | Sale | 2.21 | 4,900 | 10,818 | 0 | Jun 16 05:03 PM |
| CRMD | Pfaffle Antony | Interim Chief Medical Officer | Jun 13 '16 | Option Exercise | 0.68 | 443 | 301 | 443 | Jun 14 04:25 PM |
| CRMD | Pfaffle Antony | Interim Chief Medical Officer | Jun 10 '16 | Option Exercise | 0.68 | 5,000 | 3,400 | 5,000 | Jun 14 04:25 PM |
| CRMD | Pfaffle Antony | Interim Chief Medical Officer | Jun 10 '16 | Sale | 2.28 | 5,000 | 11,406 | 0 | Jun 14 04:25 PM |
| CRMD | Pfaffle Antony | Interim Chief Medical Officer | Jun 13 '16 | Sale | 2.20 | 443 | 975 | 0 | Jun 14 04:25 PM |
| CRMD | Pfaffle Antony | Interim Chief Medical Officer | Jun 09 '16 | Option Exercise | 0.68 | 10,000 | 6,800 | 10,000 | Jun 13 05:02 PM |
| CRMD | Pfaffle Antony | Interim Chief Medical Officer | Jun 09 '16 | Sale | 2.38 | 10,000 | 23,789 | 0 | Jun 13 05:02 PM |
| CRMD | Pfaffle Antony | Interim Chief Medical Officer | May 24 '16 | Option Exercise | 0.68 | 12,700 | 8,636 | 12,700 | May 25 04:35 PM |
| CRMD | Pfaffle Antony | Interim Chief Medical Officer | May 24 '16 | Sale | 2.73 | 12,700 | 34,656 | 0 | May 25 04:35 PM |
| CRMD | Pfaffle Antony | Interim Chief Medical Officer | May 23 '16 | Option Exercise | 0.68 | 5,000 | 3,400 | 5,000 | May 24 04:23 PM |
| CRMD | Pfaffle Antony | Interim Chief Medical Officer | May 20 '16 | Option Exercise | 0.68 | 10,000 | 6,800 | 10,000 | May 24 04:23 PM |
| CRMD | Pfaffle Antony | Interim Chief Medical Officer | May 20 '16 | Sale | 2.90 | 10,000 | 28,964 | 0 | May 24 04:23 PM |
| CRMD | Pfaffle Antony | Interim Chief Medical Officer | May 23 '16 | Sale | 2.87 | 5,000 | 14,344 | 0 | May 24 04:23 PM |
| CRMD | Pfaffle Antony | Interim Chief Medical Officer | May 18 '16 | Option Exercise | 0.68 | 12,300 | 8,364 | 12,300 | May 20 04:07 PM |
| CRMD | Pfaffle Antony | Interim Chief Medical Officer | May 18 '16 | Sale | 3.21 | 500 | 1,606 | 11,800 | May 20 04:07 PM |
| CRMD | Pfaffle Antony | Interim Chief Medical Officer | May 19 '16 | Sale | 2.80 | 11,800 | 33,077 | 0 | May 20 04:07 PM |
| CRMD | Pfaffle Antony | Interim Chief Medical Officer | Jun 01 '15 | Option Exercise | 0.29 | 30,000 | 8,700 | 30,000 | Jun 03 04:32 PM |
| CRMD | Pfaffle Antony | Interim Chief Medical Officer | Jun 01 '15 | Sale | 6.37 | 30,000 | 191,052 | 0 | Jun 03 04:32 PM |
| CRMD | Pfaffle Antony | Interim Chief Medical Officer | May 13 '15 | Sale | 6.49 | 4,722 | 30,668 | 12,003 | May 15 03:20 PM |
| CRMD | Pfaffle Antony | Interim Chief Medical Officer | May 14 '15 | Sale | 6.49 | 12,003 | 77,875 | 0 | May 15 03:20 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite